FEASIBILITY STUDIES, CLINICAL TRIAL READINESS, GMP/CLINICAL TRIAL MATERIALS

NIH RePORTER · NIH · N01 · $1,046,113 · view on reporter.nih.gov ↗

Abstract

This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to understand the basis of pain and enhance clinical pain management.” Drug Manufacturing and Formulation Program; FEASIBILITY STUDIES; CLINICAL TRIAL READINESS; Good Manufacturing Practice; CLINICAL TRIAL MATERIALS

Key facts

NIH application ID
10721047
Project number
271201500005I-0-759502200001-1
Recipient
ALBANY MOLECULAR RESEARCH, INC.
Principal Investigator
MELISSA ALLARD
Activity code
N01
Funding institute
NIH
Fiscal year
2022
Award amount
$1,046,113
Award type
—
Project period
2022-07-07 → 2027-07-06